New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 Oct) has identified a range of characteristics associated with a higher risk of sudden ...
Oct 4, 2023
0
17
Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesday, a key element in President Joe Biden's push to lower health care costs ahead of the 2024 election.
Oct 3, 2023
0
0
Nearly 44,000 new cases of thyroid cancer will be diagnosed in the U.S. this year, and more than 2,000 people will die of the disease, according to the American Cancer Society.
Oct 2, 2023
0
1
The Food and Drug Administration on Friday laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar industry that the agency says poses a growing risk to patients because of potentially inaccurate ...
Sep 29, 2023
0
0
Patients who quit smoking after undergoing percutaneous coronary intervention (PCI) for narrowed arteries have similar outcomes as non-smokers during four years of follow-up after the procedure, according to a large study ...
Sep 26, 2023
0
1
The pain from a heart attack is so bad that—if you can imagine—it can feel like an elephant sitting on you. Patients with sickle cell disease, a genetic condition affecting the red blood cells, report that this kind of ...
Sep 18, 2023
0
1
A chemotherapy drug used to fight bone-marrow cancer has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.
Sep 18, 2023
0
2
A team of medical researchers and doctors affiliated with multiple institutions in the U.S. has found, via clinical trial, that the aldosterone synthase inhibitor lorundrostat is likely safe to use for reducing blood pressure ...
Patients who have suffered a heart attack should immediately be offered a combination of cholesterol lowering drugs with statins and ezetimibe, according to research published in the Journal of the American Heart Association.
Sep 6, 2023
0
8
In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a "gamechanger." Gamechanger is a word used far too often by journalists to describe ...
Sep 6, 2023
0
1
